272 related articles for article (PubMed ID: 26283356)
21. Foxa1 and Foxa2 orchestrate development of the urethral tube and division of the embryonic cloaca through an autoregulatory loop with Shh.
Gredler ML; Patterson SE; Seifert AW; Cohn MJ
Dev Biol; 2020 Sep; 465(1):23-30. PubMed ID: 32645357
[TBL] [Abstract][Full Text] [Related]
22. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
Elife; 2018 Nov; 7():. PubMed ID: 30475207
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.
Metzakopian E; Lin W; Salmon-Divon M; Dvinge H; Andersson E; Ericson J; Perlmann T; Whitsett JA; Bertone P; Ang SL
Development; 2012 Jul; 139(14):2625-34. PubMed ID: 22696295
[TBL] [Abstract][Full Text] [Related]
24. The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.
Wang R; Shi Y; Chen L; Jiang Y; Mao C; Yan B; Liu S; Shan B; Tao Y; Wang X
Sci Rep; 2015 Dec; 5():17826. PubMed ID: 26658322
[TBL] [Abstract][Full Text] [Related]
25. Pioneer Factors FOXA1 and FOXA2 Assist Selective Glucocorticoid Receptor Signaling in Human Endometrial Cells.
Whirledge S; Kisanga EP; Taylor RN; Cidlowski JA
Endocrinology; 2017 Nov; 158(11):4076-4092. PubMed ID: 28938408
[TBL] [Abstract][Full Text] [Related]
26. FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Orstad G; Fort G; Parnell TJ; Jones A; Stubben C; Lohman B; Gillis KL; Orellana W; Tariq R; Klingbeil O; Kaestner K; Vakoc CR; Spike BT; Snyder EL
Dev Cell; 2022 Aug; 57(15):1866-1882.e10. PubMed ID: 35835117
[TBL] [Abstract][Full Text] [Related]
27. Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.
Suda Y; Kuzumaki N; Narita M; Hamada Y; Shibasaki M; Tanaka K; Tamura H; Kawamura T; Kondo T; Yamanaka A; Narita M
Biochem Biophys Res Commun; 2018 Feb; 496(4):1102-1108. PubMed ID: 29378186
[TBL] [Abstract][Full Text] [Related]
28. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.
Hwang DY; Ardayfio P; Kang UJ; Semina EV; Kim KS
Brain Res Mol Brain Res; 2003 Jun; 114(2):123-31. PubMed ID: 12829322
[TBL] [Abstract][Full Text] [Related]
29. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.
Domanskyi A; Geissler C; Vinnikov IA; Alter H; Schober A; Vogt MA; Gass P; Parlato R; Schütz G
FASEB J; 2011 Sep; 25(9):2898-910. PubMed ID: 21593433
[TBL] [Abstract][Full Text] [Related]
30. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA.
Sekiya T; Muthurajan UM; Luger K; Tulin AV; Zaret KS
Genes Dev; 2009 Apr; 23(7):804-9. PubMed ID: 19339686
[TBL] [Abstract][Full Text] [Related]
31. Forkhead box A1 (FOXA1) and A2 (FOXA2) oppositely regulate human type 1 iodothyronine deiodinase gene in liver.
Kanamoto N; Tagami T; Ueda-Sakane Y; Sone M; Miura M; Yasoda A; Tamura N; Arai H; Nakao K
Endocrinology; 2012 Jan; 153(1):492-500. PubMed ID: 22067325
[TBL] [Abstract][Full Text] [Related]
32. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2.
Bochkis IM; Schug J; Ye DZ; Kurinna S; Stratton SA; Barton MC; Kaestner KH
PLoS Genet; 2012; 8(6):e1002770. PubMed ID: 22737085
[TBL] [Abstract][Full Text] [Related]
34. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.
DeGraff DJ; Grabowska MM; Case TC; Yu X; Herrick MK; Hayward WJ; Strand DW; Cates JM; Hayward SW; Gao N; Walter MA; Buttyan R; Yi Y; Kaestner KH; Matusik RJ
Lab Invest; 2014 Jul; 94(7):726-39. PubMed ID: 24840332
[TBL] [Abstract][Full Text] [Related]
35. Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.
Golden JP; Demaro JA; Knoten A; Hoshi M; Pehek E; Johnson EM; Gereau RW; Jain S
J Neurosci; 2013 Oct; 33(43):17095-107. PubMed ID: 24155314
[TBL] [Abstract][Full Text] [Related]
36. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues.
Besnard V; Wert SE; Hull WM; Whitsett JA
Gene Expr Patterns; 2004 Dec; 5(2):193-208. PubMed ID: 15567715
[TBL] [Abstract][Full Text] [Related]
38. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
39. M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location.
Foster DJ; Gentry PR; Lizardi-Ortiz JE; Bridges TM; Wood MR; Niswender CM; Sulzer D; Lindsley CW; Xiang Z; Conn PJ
J Neurosci; 2014 Feb; 34(9):3253-62. PubMed ID: 24573284
[TBL] [Abstract][Full Text] [Related]
40. The Foxa family of transcription factors in development and metabolism.
Friedman JR; Kaestner KH
Cell Mol Life Sci; 2006 Oct; 63(19-20):2317-28. PubMed ID: 16909212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
